Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Intertek shares slide as FX headwinds and guidance cuts overshadow solid H1

(Sharecast News) - Shares in quality assurance firm Intertek were firmly in the red early on Friday as investors looked past a resilient H1 performance to focus on mounting FX pressures and trimmed growth expectations across several business units. Intertek said H1 revenues rose 4.5% at constant currency to £1.67bn, while like-for-like growth was led by its consumer products and corporate assurance units. Adjusted operating profits climbed 9.7% to £276.3m, and earnings per share rose 12.6% at constant rates. Margins improved by 80 basis points to 16.5% and the FTSE 100-listed group also said it had maintained strong cash conversion at 118%, generating £266m in adjusted operating cash flow.

However, foreign exchange headwinds overshadowed Intertek's performance as it warned FX would now create a 350-basis-point headwind to revenues and a 500-basis-point headwind to earnings, up from previous estimates of 250 and 350 basis points, respectively.

Intertek also said its Health & Safety, Industry & Infrastructure, and World of Energy divisions all fell short of quarterly expectations, with the latter reporting flat organic growth against consensus estimates of a 1.6% increase.

Looking ahead, Intertek said it was on track to meet medium-term targets, including mid-single digit revenue growth and margins above 18.5%, but a decline in adjusted operating margins in its energy, I&I, and H&S divisions, as well as cuts to full-year organic growth guidance from mid-single digit to low in H&S and I&I, weighed on the stock at the open.

Analysts at Shore Capital said: "The business Assurance, Testing, Inspection, Certification Services specialist (ATIC) has reported H1 results which feel a little light to our expectations, but no-doubt in the consensus range. We expect to retain our FY forecasts, noting this year's significant FX impacts on translation. The reporting style is as ebullient as ever, which, to our minds, gets in the way of deciphering the actual progress on growth and margins."

"We struggle to see where the valuation upside for Intertek emerges in the medium-term. Our DCF derived fair value estimate remains in the 4500p/share range (FY25F FCF yield 4.3%). To upgrade our fair value meaningfully, we would have to accelerate revenue growth beyond the Group mid-single digit target inherent Intertek's guidance, noting the long-term organic growth performance achieved in recent years around the +3% to +4% level. Alternatively, higher margin assumptions could be made: sustaining the EBIT margin at 18.5% (the new stated ambition) to the terminal value year; yet is this tenable given competition, evolving markets and cycles?"

As of 1025 BST, Intertek shares were down 7.41% at 4,574p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.